Related by context. All words. (Click for frequent words.) 73 novel therapeutics 67 therapeutics 64 systemic RNA interference 64 commercializing anti infective 64 oncology therapeutics 64 immunologic diseases 63 commercializing therapeutic 63 OTCBB NVLT biopharmaceutical 63 NASDAQ SNTA biopharmaceutical 63 Nasdaq IMMU biopharmaceutical 63 antibody therapeutics 63 novel RNAi therapeutics 63 therapeutic monoclonal antibodies 63 small molecule 63 microRNA therapeutics 63 biopharmaceutical 62 immuno inflammatory diseases 62 cancer therapeutics 62 commercializing novel 62 inflammatory diseases 62 therapeutic antibodies 62 ocular diseases 62 Nasdaq HALO biopharmaceutical 62 commercializing novel biotherapeutics 61 inflammatory autoimmune 61 Nasdaq LXRX biopharmaceutical 61 targeted immunotherapies 61 peptide peptide mimetic 61 protein therapeutics 61 immunotherapeutics 61 dermatological diseases 61 ophthalmic diseases 60 ophthalmic therapeutics 60 engineered proteases 60 Novelos Therapeutics Inc. 60 Nasdaq MITI biopharmaceutical 60 Inc. NASDAQ CRIS 60 novel anti infective 59 proliferative diseases 59 human antibody therapeutics 59 BioMarin develops 59 RNA interference RNAi therapeutics 59 commercializes innovative biopharmaceuticals 59 novel immunotherapies 59 RNAi therapeutics 59 autoimmune inflammatory 59 novel antibody therapeutics 59 bio therapeutics 58 cardiovascular metabolic 58 small molecule agonists 58 CNS disorders 58 osteolytic bone disease 58 NASDAQ AVEO biopharmaceutical 58 biotherapeutics 58 novel antiviral therapeutics 58 Nasdaq RGDX 58 Nasdaq IDRA 58 NASDAQ PPHM clinical 58 ALN PCS 58 Biomoda www.biomoda.com 58 OTCBB INSV 58 renin inhibition promising 57 monoclonal antibody therapeutics 57 NASDAQ ALTH biopharmaceutical 57 AKIP ™ 57 target Galectin receptors 57 enhance ApoA 57 expanded autologous cellular 57 advancing novel biotherapeutics 57 NASDAQ OPXA 57 anti infective treatments 57 Response Genetics Inc. 57 autologous cellular therapies 57 Nasdaq ENZN 57 antiviral therapeutics 57 Opexa Therapeutics Inc. 57 Nasdaq OMER biopharmaceutical 57 oncolytic viruses 57 anticancer therapeutics 57 epigenetic enzymes 57 Nasdaq CYTR biopharmaceutical 57 NovaBay Aganocide compounds 57 purinergic receptors P#X# 57 Ibis T# TM 57 histone methyltransferases HMTs 56 molecular imaging radiopharmaceuticals 56 MDRNA proprietary 56 commercializes biotherapeutics 56 immunological diseases 56 OTCBB IMUC biotechnology 56 fibrotic diseases 56 NASDAQ CORT 56 OTCBB QTXB 56 novel peptide therapeutics 56 AMEX REX 56 oral JAK#/JAK# inhibitor 56 TSX VIR 56 peptide therapeutics 56 Nasdaq IDIX biopharmaceutical 56 monoclonal antibodies 56 Morria Biopharmaceuticals Plc 56 biopharmaceuticals 56 specialty pharmaceutical 56 commercializing aptamer therapeutics 56 infectious diseases autoimmune 56 Applied NeuroSolutions 56 Viprovex TM 56 modified glutathione analog 56 Frankfurt XMP 56 small molecule modulators 56 Receptos 56 Archemix Corp. 56 antibiotic anti infective 56 NYSE Amex PBTH 56 Board LWLG technology 56 Inc. Nasdaq LXRX 56 RNAi therapeutic 56 antisense drugs 56 Inc. NASDAQ OPXA 56 Inc. NASDAQ AEZS 56 Lexicon Pharmaceuticals Inc. 56 autologous cell 55 www.ucb group.com 55 derivatives Radilex TM 55 OTCBB NRGX biotechnology 55 neuro inflammatory 55 Homspera TM 55 identify protein biomarkers 55 metabolic diseases 55 StromaCel Inc. 55 topically delivered 55 autoimmune indications 55 FOLOTYN ® 55 YM AIM YMBA 55 NASDAQ CYTR biopharmaceutical 55 stem cell therapeutics 55 novel peptides 55 RNAi therapeutic targeting 55 OTCBB FCSC biotechnology 55 comprise Alnylam RNAi 55 product platforms AZX# 55 Nasdaq MNKD focused 55 Tranzyme 55 NuMimetic TM 55 commercialize microRNA therapeutics 55 targeted radiotherapeutic 55 polymer conjugate technology 55 Neurogen Corporation 55 pralatrexate injection folate analogue 55 selective androgen receptor modulators 55 ImmuneRegen BioSciences Inc. 55 topical anti infective 55 Akela Pharma Inc. 55 Ception Therapeutics 55 antisense drug 55 VIA Pharmaceuticals 55 CRMD pharmaceutical 55 Nasdaq ASTM 55 siRNA therapeutics 55 Inc. Nasdaq NEXM 55 Inc. Nasdaq RNVS 55 tiapamil 55 mediate RNAi 55 OTCBB URGP specialty 55 OTCBB OHRP 55 vaccines oncolytic virus 55 inflammation autoimmune diseases 55 anticoagulant reversing agent 55 Nanobodies ® novel 55 siRNA compounds 55 OTCBB FCSC 55 proprietary NexACT ® 55 Inc. NASDAQ IDMI 55 AMEX ISV 55 MTP inhibitor 55 small molecule inhibitors 54 G Protein Coupled 54 NYSE Amex NBY clinical 54 molecular biomarkers 54 commercializing innovative 54 Nasdaq PARD biopharmaceutical 54 OTC Bulletin Board LWLG 54 psoriasis rheumatoid arthritis 54 NYSE Amex AEN 54 DOS# 54 CAMBRIDGE Mass. Alnylam Pharmaceuticals 54 Inc. Nasdaq NLTX 54 adrenal steroid hormones 54 Omeros Corporation 54 infectious diseases autoimmune diseases 54 Anadys Pharmaceuticals Inc. 54 novel kinase inhibitors 54 therapeutic peptides 54 kidney urologic 54 neurodegenerative diseases 54 Adnectin 54 viral diseases 54 ImmunoCellular Therapeutics Ltd. 54 NYSE Amex RNN 54 aptamer therapeutics 54 PDE4 modulators 54 Nasdaq DYAX 54 acne impetigo 54 taste modulators 54 Alzheimer disease cognitive impairment 54 Inc. Nasdaq ANTH 54 targeted immunotherapeutics 54 NASDAQ BTRX pharmaceutical 54 Inc. NASDAQ IDIX 54 therapeutic peptide 54 OTCBB IMUC 54 biomarker discovery 54 Brussels THR 54 Nasdaq RXII 54 Nasdaq VRTX 54 neuropathic pain metabolic diseases 54 Agios Pharmaceuticals 54 PRNewswire FirstCall BioSpecifics Technologies 54 CCR9 antagonist 54 Amex PTN 54 Cellgate Inc. 54 NasdaqCM PSTI DAX PJT 54 molecular radiotherapeutics 54 OTCBB NPHC biotechnology 54 NASDAQ DYAX developer 54 orally administered pharmacological chaperones 54 theranostic 54 Corp. Nasdaq BSTC 54 gastrointestinal disorders characterized 54 gastro intestinal inflammation 54 romazarit 54 Genaera Corporation 54 Nasdaq TARG 54 JAK1 54 antibody therapies 54 proprietary biomaterials 54 ArQule Kinase Inhibitor Platform 54 HepDirect R 54 OTCBB CGXP 54 including thyroiditis RA 54 commercializing oxidized glutathione 54 theranostics 54 XSSE OXGN 54 Inc. Nasdaq VIAP 54 ImmunoGen Inc. 54 Inc. Nasdaq ALNY 54 liver cancers hypercholesterolemia 54 M2 subunit 54 imaging radiopharmaceuticals 54 autoimmune diseases inflammatory 54 isoform selective 54 Akebia Therapeutics 54 TSX VENTURE DMA 54 commercialize Aganocides 54 Nile Therapeutics 54 Enhanze TM Technology 54 FoldRx Pharmaceuticals Inc. 54 Receptors GPCRs 54 immunotherapies 54 Pluristem Therapeutics Inc. 54 NASDAQ PANC biotechnology 54 bioactive lipids 53 OTCBB IMNR 53 dermatology therapies 53 humanized monoclonal antibodies 53 Nasdaq MBRX announced 53 Inc. Nasdaq IMMU 53 Ph.D. Targacept 53 Ceragenix Pharmaceuticals Inc. 53 ASONEP TM 53 intracellular signaling pathways 53 ribonucleotide reductase clinically validated 53 personalized cellular immunotherapy 53 Nasdaq ALNY 53 Nasdaq CRXL 53 Avila Therapeutics 53 commercializes therapeutics 53 superior bioprocessing 53 Alfacell proprietary ribonuclease 53 Inc. Nasdaq SUPG 53 AVEO Pharmaceuticals Inc. 53 diseases fat malabsorption 53 antibody fragment therapeutics 53 Epeius Biotechnologies Corporation 53 Provectus Pharmaceuticals specializes 53 mucosal vaccines 53 therapeutic antibody 53 novel biotherapeutics 53 Fibroblast Growth Factor Receptor 53 NYSE Amex PTN 53 RONDEL ™ 53 BHT DNA 53 molecular diagnostics 53 liposomal delivery 53 Adrenomyeloneuropathy AMN HIV 53 clinically validated targets 53 autologous cellular therapy 53 commercialize microRNA 53 Adenosine Therapeutics 53 Nasdaq IDIX 53 PRNewswire FirstCall Halozyme Therapeutics 53 NASDAQ LGND 53 PROLOR Biotech Inc. 53 novel therapeutic antibodies 53 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 53 TSX YM AIM 53 lipid particles SNALP 53 Tranzyme Pharma 53 Immtech Pharmaceuticals Inc. 53 nitric oxide donating 53 ophthalmology oncology 53 NASDAQ IMCL 53 proprietary dermal 53 diabetic retinopathy hyphema glaucoma 53 superior ophthalmologic products 53 endocrine diseases 53 Metabasis Therapeutics Inc. 53 P#X# antagonist 53 humanized monoclonal antibody 53 allosteric modulators 53 Sangamo ZFP technology 53 Merrimack Pharmaceuticals 53 specialty biopharmaceutical 53 immunotherapeutic approaches 53 synthetic cannabinoid compounds 53 developing Surfactant Replacement 53 Repligen Corporation 53 include Altastaph TM 53 novel peptide 53 mGluR4 mGluR2 mGluR5 53 Inc. AMEX YMI 53 Solazed TM 53 rheumatoid arthritis multiple sclerosis 53 therapeutic proteins 53 OTCBB NRGX 53 Protein Polymer Technologies 53 Spiro Rombotis President 53 subsidiaries InnerCool Therapies 53 topical anti infectives 53 hematologic diseases 53 commercializes diversified 53 epothilones 53 adrenergic regulation 53 selective angiogenic kinase inhibitor 53 Curaxins 53 siRNA therapeutic 53 PRNewswire FirstCall Senomyx 53 OTCBB CHKT 53 OTCBB DORB DOR 53 SARMs 53 Intarcia 53 non personalized allogeneic 53 Spectrum Pharmaceuticals acquires 53 biotherapeutic 53 OTCBB AEMD pioneer 53 antiangiogenesis therapies 53 Selective Electrochemical Tumor Ablation 53 IAP inhibitors 53 COX FP Reuters NCOX.PA 53 HepaLife Technologies Inc. 53 Intellikine 53 THR beta agonist 53 #/#/# Cytokinetics Incorporated 53 monocytogenes Listeria vaccines 53 anticancer compounds 53 Inc. OTCBB LPTN 53 acquires researches develops 53 chemical entities NCEs 53 Friedreich Ataxia FRDA 53 NASDAQ DYAX 53 virology therapeutics 53 molecular imaging radiopharmaceutical 53 PRNewswire FirstCall Neurogen 53 formed Alnylam Biotherapeutics 53 cardiovascular gastrointestinal 53 antibody therapeutics targeting 53 Nucleic Acid Detection Immunoassay 53 AIM SLN 52 OTC BB PVCT 52 PROT biotechnology 52 aptamers 52 PROfusion 52 sirtuin inhibitor program 52 CYT# novel 52 IIB ActRIIB 52 degenerative disorders 52 CorMedix NYSE Amex 52 myeloproliferative disorders 52 San Diego Amira Pharmaceuticals 52 NYSE Amex PIP biodefense 52 Amedica Corporation 52 developing chemokine 52 Tissue Repair Company 52 Adeona Pharmaceuticals Inc. 52 rxRNA 52 targeted anticancer therapeutics 52 vitreoretinal disorders 52 protein ADNP 52 NASDAQ OPTR 52 myelofibrosis polycythemia vera 52 biased ligand 52 developing Bicifadine serotonin 52 Injury ALI 52 patented NanoStat TM 52 Squalamine 52 neuroblocking technology 52 injury ischemic spastic 52 delta isoform 52 neurological diseases 52 diagnostic biomarkers 52 NASDAQ ABII 52 4SC AG ISIN DE# 52 Ardea Biosciences Inc. 52 Nasdaq IMGN biopharmaceutical 52 Aeolus Pharmaceuticals 52 NovaBay Pharmaceuticals Inc. 52 PRNewswire FirstCall Aeterna Zentaris 52 Epiphany Biosciences 52 3 kinase PI3K 52 Akesis Pharmaceuticals 52 humanized anti 52 Ardea Biosciences 52 Inc. Nasdaq INFI 52 LNP formulations 52 NASDAQ FLML 52 investigational monoclonal antibody 52 EPIX Pharmaceuticals Inc. 52 novel orally administered 52 Protein Kinase C 52 About Positron Positron 52 investigational pan BCR 52 novel immunomodulatory 52 OTCBB HXBM developer 52 Sangamo BioSciences Inc. 52 Sphingomab TM 52 Nasdaq HALO 52 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 52 Alvine Pharmaceuticals 52 AKELA Pharma Inc. 52 Adherex Technologies Inc. 52 TRACON Pharmaceuticals 52 IAP inhibitor 52 biologically validated targets 52 eye vitreous hemorrhage 52 Locked Nucleic Acid 52 c Raf kinase 52 OTCBB CHKT biotechnology 52 candidates Azedra TM 52 rheumatoid arthritis psoriasis 52 immunotherapeutic 52 ArQule Kinase Inhibitor 52 Nasdaq OMER 52 Hsp# inhibitors 52 subsidiaries Laboratorios Belmac Laboratorios 52 cognitive impairment associated 52 Adamis Viral Therapies 52 prostones 52 Inc. Nasdaq IMGN 52 neurodegenerative disorders 52 TSX CTI 52 Catalyst Biosciences 52 commercializing dermatological products 52 cardiac muscle contractility 52 use neuroblocking technology 52 unmet medical 52 rusalatide acetate 52 PRNewswire FirstCall Anesiva 52 RON Notch 52 fibrotic disorders 52 Combivir Kivexa 52 Anchor Therapeutics 52 NexVas TM 52 Etubics 52 Inc. NASDAQ AGIX 52 preclinical compounds 52 FGFR 52 Therapeutic Competitors companiesandmarkets.com adEgemonye 52 NASDAQ EPIX biopharmaceutical 52 Company NASDAQ MDCO 52 Inc. Nasdaq IDMI 52 PRNewswire FirstCall Nastech Pharmaceutical 52 retinal disorders 52 peptidic compound 52 passive immunotherapy products 52 Idun Pharmaceuticals 52 Inovio Biomedical AMEX INO 52 OSI Prosidion 52 TSX VENTURE GAP 52 Liprotamase 52 NASDAQ CRXL 52 Kleanthis G. Xanthopoulos Ph.D. 52 Idera Pharmaceuticals 52 OTCBB NVLT 52 PEGylation technology 52 customizable drug eluting 52 Inc. Nasdaq IDIX 52 DPX Survivac 52 cystic fibrosis inflammation autoimmune 52 peptibody 52 Genesis Biopharma Inc. 52 liver cancers TTR 52 XmAb ® 52 ZFN TM 52 influenza hypercholesterolemia 52 NTDDS 52 2 inhibitor CYT# 52 investigational humanized monoclonal antibody 52 Nasdaq VNDA 52 ALN TTR 52 NicOx Bloomberg 52 Nasdaq CGEN 51 Mersana Therapeutics 51 Factor VIIa 51 AEMD 51 humanized antibody 51 CytRx Corporation 51 treat gastrointestinal disorders 51 Inc. OTCBB SNWV 51 AN# novel 51 OTCBB HPLF FWB HL1 51 cardiovascular disorders 51 IR BioSciences Holdings 51 pharmaceuticals nutritionals 51 live attenuated Listeria 51 DiLA2 51 Through Glycoscience R 51 Nasdaq RDEA 51 inflammatory disorders 51 Targanta Therapeutics Corporation 51 Adlyfe 51 developing topically administered 51 PNP inhibitor 51 Functional Somatic Syndromes 51 Crucell NV NYSE Euronext 51 Supernus Pharmaceuticals 51 neuro inflammatory disorders 51 Ophthotech 51 LentiVector technology 51 Oracea TM 51 anti infective 51 MP4 molecule 51 Inc. ProMetic www.prometic.com 51 taxane derivative 51 New Chemical Entities 51 Quark Biotech Inc. 51 acetonide FA 51 Pentad TM 51 Group NV Pharming 51 enhanced skin permeation 51 XmAb ™ 51 Nasdaq DSCI 51 Acetylon 51 PRNewswire FirstCall YM BioSciences 51 NeurAxon Inc. 51 molecular imaging pharmaceuticals 51 Acuity Pharmaceuticals 51 intranasal vaccines derived 51 Nasdaq INCY 51 Luna Innovations Incorporated www.lunainnovations.Motilal Oswal Commodities 51 AAV vector 51 Anacor 51 SGLT Inhibitors 51 PEGylation 51 Baxa customer 51 Vaccinex 51 OTCBB PYTO 51 AMEX ONI 51 commercialize deforolimus 51 www.ucb.com 51 AutoloGel tm System 51 Aestus Therapeutics 51 polymerase inhibitors 51 OTCBB TDLP 51 ALTROPANE R 51 DURECT proprietary 51 ADVEXIN p# therapy 51 Corporation Nasdaq CRGN 51 activin receptor type 51 Nasdaq PARD 51 oncology anti infective 51 biologic therapeutics 51 siRNA conjugates 51 Nasdaq LEXG 51 cardiac muscle myosin 51 Regado Biosciences 51 OTCBB JMAR leading 51 DNAi 51 Therapies SRT 51 XL# anticancer compounds 51 Inc. Nasdaq ONTY 51 JAK2 inhibitor 51 Ceregene 51 TSX AEZ 51 renal diseases 51 NASDAQ OMX NORDIC ACTI 51 class collagenase 51 Ampakine compounds 51 Dynavax Technologies Corporation 51 therapeutic anticancer 51 Delta opioid receptor 51 Inc. Nasdaq FVRL 51 eSensor detection technology 51 polyneuropathy HIV DSP 51 commercializes innovative 51 NYSE Amex RGN 51 Avian Transgenic Technology 51 Panacos Pharmaceuticals Inc. 51 rheumatoid arthritis Crohn disease 51 equine osteoarthritis 51 oral transdermal 51 Amir Avniel 51 commercializing proteomics discoveries 51 mGluR4 51 ABL inhibitor 51 KellBenx 51 Aganocide ® 51 sirtuin therapeutics 51 diarrhea predominant irritable 51 secretory phospholipase A2 51 XmAb TM 51 Nanobody ® 51 immuno oncology 51 Amex KAL 51 transthyretin mediated amyloidosis ATTR 51 targeted anticancer biopharmaceuticals 51 Affimed Therapeutics AG 51 fusion proteins 51 multivalency toward drug 51 Nasdaq IVGN 51 treat refractory angina 51 Nasdaq FOLD 51 Bone Graft Substitute 51 anticancer therapies 51 Disease IBD 51 Cytokinetics cardiac 51 Uli Hacksell Ph.D. 51 Garo H. 51 Cobalamin TM mediated 51 OTCBB PYTO FWB ET6 51 Nasdaq XTLB 51 Unigene Laboratories Inc. 51 Shrink OTC Bulletin 51 Callisto Pharmaceuticals Inc. 51 proprietary Dicer Substrate Technology 51 gastrointestinal disorders 51 immuno pharmaceutical 51 OGeS 51 doxorubicin Transdrug R 51 FoldRx 51 infectious autoimmune 51 engineered RAP peptides 51 autoimmune diseases inflammation 51 Nasdaq AFFY today 51 rxRNA compounds 51 Nanobody 51 regenerative therapies 51 alfimeprase direct 51 neuropathic pain spasticity 51 Myrexis Inc. 51 recombinant polyclonal antibodies 51 proprietary LNA 51 therapeutic monoclonal antibody 51 BioFocus DPI Galapagos 51 stage hypoxia activated 51 Nasdaq ENMD 51 platform HDL Mimetic 51 Inc. OTCBB SPRX 51 diabetes irritable bowel 51 blood serum biomarkers 51 www.nanoviricides.com 51 diagnostic assays 51 REGENERX BIOPHARMACEUTICALS INC. 51 Inc. www.sanuwave.com 51 diagnostic molecular imaging 51 humanized antibodies 51 Zemiva TM 51 agonist compounds 51 GlycoPEGylated hemostasis compounds 51 Corp. NASDAQ SNTA 51 NASDAQ EPIX 51 Viprovex R 51 SANUWAVE Health 51 AB OMXS BINV 51 pharmacogenomic tests 51 GI motility disorders 51 Nasdaq IMGN biotechnology 51 Promedior 51 Cerimon Pharmaceuticals Inc. 51 Æterna Zentaris Inc. 51 RONDEL TM 51 OTCBB HNAB 51 Nasdaq MYRX 51 OTCBB IBPM 51 PRNewswire FirstCall Favrille 51 Nasdaq AEZS 51 Mirna Therapeutics 51 Spiegelmers ® 51 multi kinase inhibitor 51 NASDAQ BSMD medical 51 PRNewswire FirstCall Idenix Pharmaceuticals 51 targeted pulsed electromagnetic 51 protein kinase inhibitors 51 fibrosis IPF 51 anti infective compounds 51 Personalized Immunotherapy 51 Nasdaq TGEN 51 Inc. dba Vitro 51 catalytic antioxidant compounds 50 Restoraderm R technology 50 Stapled Peptide 50 Selecta Biosciences Inc. 50 Davunetide 50 NASDAQ PGNX 50 cardiovascular stents 50 rheumatoid arthritis thrombocytopenia 50 multiple sclerosis rheumatoid arthritis 50 signal transduction inhibitors 50 attach auristatin 50 Inc. NASDAQ SNUS 50 Palatin Technologies Inc. 50 Genasense evaluating 50 hypercholesterolemia liver 50 Nastech Pharmaceutical Company 50 molecular diagnostic tests 50 histone deacetylase HDAC 50 autoimmune disorders 50 Therapeutic Competitors Companies 50 Corporation Nasdaq LTXC 50 cancer therapeutics Adherex 50 Nasdaq IDRA today 50 NNR Therapeutics 50 Nasdaq FURX 50 calcium phosphate nanotechnology CaP 50 NASDAQ INGN 50 flavors flavor enhancers 50 INS# [001] 50 Algeta ASA OSE ALGETA 50 NasdaqGM SPPI commercial 50 Kosan dependence 50 Taligen Therapeutics 50 molecular chaperone regulation 50 Urigen NA Inc. 50 Nautilus Biotech 50 hematological diseases 50 TSX TKM 50 TM Aganocide 50 TSX ONY 50 commercializing interventional 50 Urigen Pharmaceuticals Inc. 50 DiLA2 platform 50 DsiRNA 50 BioVex Inc 50 investigational therapies 50 Pervasis Therapeutics Inc. 50 ProNAi 50 VentiRx 50 cytoskeleton enables 50 Anticalins R 50 NASDAQ VNDA 50 Sunesis Pharmaceuticals 50 Alnara Pharmaceuticals Inc. 50 SCYNEXIS 50 TLR Therapeutics 50 Fibrocell Science 50 TetraLogic Pharmaceuticals 50 Lorus biopharmaceutical company 50 NASDAQ ABII fully 50 familial amyloidotic polyneuropathy FAP 50 including HGF ErbB3 50 A3 adenosine receptor 50 small molecule defensin 50 Lipid Sciences Inc. 50 Ohr Pharmaceutical Inc. 50 mediated amyloidosis ATTR hypercholesterolemia 50 delay bone metastases 50 biochemical profiling 50 HIF biology 50 small molecule activators 50 hereditary emphysema 50 PRNewswire FirstCall Lightwave Logic 50 TÎ ² 4 50 OXIGON TM 50 Optimer Pharmaceuticals Inc. 50 platinum chemotherapeutic 50 Pervasis 50 NASDAQ CYPB 50 Inc. Nasdaq AVRX 50 Nasdaq SSRX 50 monoclonal antibody 50 NASDAQ ZIOP announced 50 QuantRx Biomedical Corporation 50 Synergy Pharmaceuticals 50 AVANIR Pharmaceuticals 50 Exelixis compounds 50 lead molecular radiotherapeutic 50 NYSE Amex JAV 50 Inc. http:/www.endocare.com 50 anti infectives 50 prophylactic vaccines 50 OTCBB DORB 50 Nasdaq SOMX specialty 50 Aradigm Corporation 50 Euronext Paris BIO 50 Celsion Corporation 50 regenerative medicine 50 commercialize minimally invasive 50 NexACT ® technology 50 kinase inhibitors 50 CNW Telbec Aeterna Zentaris 50 Phenomix Corporation 50 HuCAL PLATINUM ® CysDisplay 50 oncolytic 50 neurology immunology 50 Fibrocell Science Inc. 50 neuromodulation therapies 50 HCV NS3 protease 50 commercializes proprietary 50 molecular therapeutics immunotherapies 50 Adnexus Therapeutics 50 siRNA delivery 50 Curaxin 50 targeted radiotherapeutics 50 PolyTherics 50 nephrology oncology supportive 50 Piramed 50 miRNA therapeutics 50 Ltd. OTCBB IMUC 50 IMiDs R 50 muscarinic receptor agonists 50 cosmetic cosmeceutical products 50 HepDirect prodrug 50 PRNewswire FirstCall Immunomedics 50 Eg5 kinesin spindle 50 Corp. www.anavex.com 50 Nasdaq MNKD 50 aTyr Pharma 50 pharmacological chaperone 50 small molecule inhibitor 50 denufosol tetrasodium 50 Neuroptix 50 NovaBay Pharmaceuticals 50 ADCC enhanced 50 HSP# inhibitors 50 Ore Pharmaceuticals 50 Hepatitis C Virus HCV 50 Nasdaq SIGA 50 Neogenix 50 pharmacological chaperones 50 BIOGUARD TM 50 mTOR mammalian target 50 bioengineers novel 50 ViroPharma Incorporated 50 neuro degenerative diseases 50 atopic dermatitis neonatal 50 postherpetic neuralgia PHN painful 50 autoimmune uveitis 50 beta secretase inhibitors 50 molecular chaperone technology 50 innovative signaling pathway 50 Logical Therapeutics 50 immunotherapies 2A/Furin 50 NASDAQ CLDX 50 potently silencing specific 50 nucleoside tide analogs 50 cardiac myosin 50 OTCBB ARDM 50 Lexicon Genetics 50 Transdel Pharmaceuticals Inc. 50 skeletal muscle weakness 50 Nasdaq GENR 50 KL4 Surfactant 50 TSX VBI 50 Announces Poster Presentations 50 Protalex Inc. 50 Plexxikon 50 prostone 50 injectable pharmaceutical 50 Hybridon 50 CDK cyclin dependent 50 AVEO Pharmaceuticals NASDAQ 50 PAION AG ISIN 50 oncology indications 50 NASDAQ TGEN 50 antiviral compounds 50 Somaxon Pharmaceuticals Inc. 50 Nuron Biotech 50 Prodarsan R 50 immune modulators 50 NovaDel oral spray 50 RNA antagonist 50 Hana Biosciences NASDAQ HNAB 50 InNexus Biotechnology 50 anticancer agents 50 rheumatoid arthritis psoriasis Crohn 50 small molecule glucokinase 50 Insmed Incorporated NASDAQ INSM 50 metabolic disorders 50 OTCBB PWRM.OB 50 autoimmune diseases 50 subsidiaries visit http:/www.apricusbio.com 50 biologic treatments 50 recombinant vaccines 50 CD3 monoclonal antibody 50 Smac mimetics 50 Dicer Substrate Technology 50 Nereus Pharmaceuticals 50 neovascular diseases 50 commercialize becocalcidiol patented 50 Nasdaq INHX 50 PsychoGenics 50 NASDAQ INHX 50 Predictive medicine 50 Anaphore 50 developing Zerenex TM 50 Cerus Corporation 50 Soliris eculizumab 50 Rexahn Pharmaceuticals Inc. 50 HepDirect technology 50 GERD migraine headaches 50 TransMolecular 50 antisense oligonucleotides 50 Charlesson 50 Epizyme 50 therapies 50 stable nucleic acid 50 NASDAQ ALNY 50 specialty pharmaceuticals 50 functional genomics 50 BioSphere principal 50 Ikonisys 50 antiinfective products 50 Fibromyalgia Syndrome FMS 50 TSX AMB 50 severe malignant osteopetrosis 50 MyVax R 50 Hsp# inhibition 50 Onalta 50 coronary stent merged 50 histone deacetylase 50 addressing idiopathic pulmonary 50 AMEX RGN 50 Inc. AMEX AEN 50 Pharsight Corporation 50 MediGene focuses 50 HepDirect 50 selective inhibitors 50 OTCBB RPBC 50 delta gamma agonist 50 KAI Pharmaceuticals Inc. 50 Peregrine Pharmaceuticals Inc. 50 DRRX 50 M# rationally 50 Affymax Inc. 50 OTCBB WYNX platform 50 Nasdaq ARGN leader 49 lipid nanoparticles 49 musculoskeletal metabolic 49 Mesoblast Limited ASX MSB 49 BioWa 49 APT Pharmaceuticals 49 GammaCan 49 PRNewswire FirstCall Palatin Technologies 49 NurOwn 49 Nasdaq DVAX 49 NexACT R 49 ALN TTR# 49 inflammatory autoimmune diseases 49 hepatitis C virus HCV 49 NASDAQ CYTR 49 migraines neurorehabilitation 49 Avalon Pharmaceuticals 49 immunomodulators 49 Xanthus Pharmaceuticals Inc. 49 TLR9 agonists 49 Ikaria Holdings Inc. 49 Oxis International 49 allosteric modulation 49 therapeutic biomaterials 49 proven DuraSite ® 49 NASDAQ ARRY 49 About Chemokine Therapeutics 49 LNPs 49 HDL Therapy 49 small molecule activator 49 Nasdaq NRGN 49 triggers apoptosis programmed 49 CoMentis 49 Calistoga Pharmaceuticals 49 proprietary PEGylation 49 NYSE Amex ANX 49 oral Janus kinase 49 Cardium Biologics medical 49 ribonucleic acid interference RNAi 49 using ImmunoGen TAP 49 molecular assays 49 selective inhibition 49 neurotology neuropsychology headaches 49 ReVision Optics 49 CB2 selective